MiMedx drove sales of its tissue grafts through means that included ‘channel stuffing,’ and it brooked little criticism, some former employees allege. The company is doing an internal investigation and preparing to restate financial results back to 2012.


20


Wall Street Journal

18 Related Articles from 2018-07-23